研发-话题@MedSci

#研发#

826篇内容 | 7094人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1300434, encodeId=3f1513004342b, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=抗艾滋病新药研发公司前沿生物IPO今日上市, objectType=article, longId=202628, objectId=b37720262836, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b37720262836, replyNumber=0, likeNumber=91, createdTime=2020-10-31, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b37720262836, moduleTitle=抗艾滋病新药研发公司前沿生物IPO今日上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b37720262836)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300433, encodeId=54cf130043398, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=Nature:同期两篇！从基础研究到药物研发，李明团队发明“癌症环境免疫疗法”, objectType=article, longId=202395, objectId=56e1202395cc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=56e1202395cc, replyNumber=0, likeNumber=82, createdTime=2020-10-24, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=56e1202395cc, moduleTitle=Nature:同期两篇！从基础研究到药物研发，李明团队发明“癌症环境免疫疗法”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=56e1202395cc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300432, encodeId=c48e13004329a, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=IDWeek 2020：默克公司将展示其广泛的抗感染药物研发管线, objectType=article, longId=202387, objectId=644e20238e88, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=644e20238e88, replyNumber=0, likeNumber=80, createdTime=2020-10-24, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=644e20238e88, moduleTitle=IDWeek 2020：默克公司将展示其广泛的抗感染药物研发管线, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=644e20238e88)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300431, encodeId=d4eb130043136, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=9月16日全球新冠肺炎（COVID-19）疫情简报，确诊超3914万，日增再创新高，国外疫苗和药物研发均不顺利, objectType=article, longId=202186, objectId=eff22021869f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eff22021869f, replyNumber=0, likeNumber=64, createdTime=2020-10-17, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eff22021869f, moduleTitle=9月16日全球新冠肺炎（COVID-19）疫情简报，确诊超3914万，日增再创新高，国外疫苗和药物研发均不顺利, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eff22021869f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300430, encodeId=22cf130043090, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=Sensible Medical：基于“透视墙”技术研发“穿戴”设备，测量肺积液管理心衰患者, objectType=article, longId=201990, objectId=762f2019907b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=762f2019907b, replyNumber=0, likeNumber=117, createdTime=2020-10-13, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=762f2019907b, moduleTitle=Sensible Medical：基于“透视墙”技术研发“穿戴”设备，测量肺积液管理心衰患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=762f2019907b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300429, encodeId=f6101300429d1, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=10月10日全球新冠肺炎（COVID-19）疫情简报，确诊超3709万，美国疫情强烈反弹，全球聚焦疫苗研发进度, objectType=article, longId=201923, objectId=ca3f20192369, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ca3f20192369, replyNumber=0, likeNumber=74, createdTime=2020-10-12, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ca3f20192369, moduleTitle=10月10日全球新冠肺炎（COVID-19）疫情简报，确诊超3709万，美国疫情强烈反弹，全球聚焦疫苗研发进度, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ca3f20192369)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300428, encodeId=6bff130042855, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=恒瑞医药正在瑞士巴塞尔建立欧洲临床研发中心, objectType=article, longId=201859, objectId=60cd2018593c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=60cd2018593c, replyNumber=0, likeNumber=58, createdTime=2020-10-10, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=60cd2018593c, moduleTitle=恒瑞医药正在瑞士巴塞尔建立欧洲临床研发中心, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=60cd2018593c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300427, encodeId=7d23130042efb, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=百时美施贵宝斥131亿美元收购心血管药物研发商 , objectType=article, longId=201808, objectId=854e201808dc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=854e201808dc, replyNumber=0, likeNumber=68, createdTime=2020-10-09, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=854e201808dc, moduleTitle=百时美施贵宝斥131亿美元收购心血管药物研发商 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=854e201808dc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300426, encodeId=8ee713004262b, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=华西医院唐承薇教授：研发成果，中国硬件设备化的消化内镜AI产品获证, objectType=article, longId=201750, objectId=e765201e501d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e765201e501d, replyNumber=0, likeNumber=67, createdTime=2020-10-07, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e765201e501d, moduleTitle=华西医院唐承薇教授：研发成果，中国硬件设备化的消化内镜AI产品获证, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e765201e501d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300425, encodeId=64581300425a7, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=翰尔西医疗：打破进口垄断，历经8年潜心研发推出国内领先的注射笔获NMPA认证, objectType=article, longId=201738, objectId=84d3201e38cc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=84d3201e38cc, replyNumber=0, likeNumber=34, createdTime=2020-10-07, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=84d3201e38cc, moduleTitle=翰尔西医疗：打破进口垄断，历经8年潜心研发推出国内领先的注射笔获NMPA认证, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=84d3201e38cc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300424, encodeId=ca91130042455, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=CSCO 2020丨CDE高级审评员夏琳：肿瘤免疫治疗药物的临床研发和审评考虑, objectType=article, longId=201052, objectId=27f8201052b6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=27f8201052b6, replyNumber=0, likeNumber=40, createdTime=2020-09-24, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=27f8201052b6, moduleTitle=CSCO 2020丨CDE高级审评员夏琳：肿瘤免疫治疗药物的临床研发和审评考虑, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=27f8201052b6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300423, encodeId=8c1e130042313, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=辉瑞未来5年研发管线大公开！, objectType=article, longId=200999, objectId=6dfd2009996f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6dfd2009996f, replyNumber=0, likeNumber=82, createdTime=2020-09-23, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6dfd2009996f, moduleTitle=辉瑞未来5年研发管线大公开！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6dfd2009996f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300422, encodeId=dd7d130042222, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=吉利德Kite副总裁离职、拜耳CEO任期延长、BMS肿瘤研发首脑加入Blueprint……, objectType=article, longId=200934, objectId=8f8c200934f5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8f8c200934f5, replyNumber=0, likeNumber=55, createdTime=2020-09-21, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8f8c200934f5, moduleTitle=吉利德Kite副总裁离职、拜耳CEO任期延长、BMS肿瘤研发首脑加入Blueprint……, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8f8c200934f5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300421, encodeId=cc1d13004215f, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=华山陈向军、俞海：西尼莫德带给中国多发性硬化患者前沿疗法，新药研发可从四个方向突破, objectType=article, longId=200726, objectId=135f200e2611, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=135f200e2611, replyNumber=0, likeNumber=74, createdTime=2020-09-17, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=135f200e2611, moduleTitle=华山陈向军、俞海：西尼莫德带给中国多发性硬化患者前沿疗法，新药研发可从四个方向突破, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=135f200e2611)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300420, encodeId=33511300420df, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=非常时期埋头研发——一家医疗器械生产企业的突围之路, objectType=article, longId=200654, objectId=c60e200654aa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c60e200654aa, replyNumber=0, likeNumber=71, createdTime=2020-09-15, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c60e200654aa, moduleTitle=非常时期埋头研发——一家医疗器械生产企业的突围之路, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c60e200654aa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300419, encodeId=24181300419c9, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=肝病研发企业新通药物完成Pre-IPO融资，预计明年在科创板上市, objectType=article, longId=200559, objectId=32db20055902, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=32db20055902, replyNumber=0, likeNumber=76, createdTime=2020-09-12, rootId=0, userName=heli0118, userId=21015, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=32db20055902, moduleTitle=肝病研发企业新通药物完成Pre-IPO融资，预计明年在科创板上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=32db20055902)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300418, encodeId=687213004183b, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=太刚了！真有人会为了新冠疫苗研发放弃赚钱…, objectType=article, longId=200433, objectId=6c67200433d6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6c67200433d6, replyNumber=0, likeNumber=39, createdTime=2020-09-10, rootId=0, userName=heli0118, userId=21015, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6c67200433d6, moduleTitle=太刚了！真有人会为了新冠疫苗研发放弃赚钱…, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6c67200433d6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300417, encodeId=b134130041ef7, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=第六批过度重复药品目录发布，企业应科学评估二甲双胍等302个品种研发风险, objectType=article, longId=200424, objectId=c5ab2004248c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c5ab2004248c, replyNumber=0, likeNumber=74, createdTime=2020-09-09, rootId=0, userName=heli0118, userId=21015, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c5ab2004248c, moduleTitle=第六批过度重复药品目录发布，企业应科学评估二甲双胍等302个品种研发风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c5ab2004248c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300416, encodeId=09c013004160d, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=8月28日全球新冠肺炎（COVID-19）疫情简报，确诊超2460万，美国制裁俄新冠病毒疫苗研发机构, objectType=article, longId=199997, objectId=e27419999e87, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e27419999e87, replyNumber=0, likeNumber=66, createdTime=2020-08-29, rootId=0, userName=heli0118, userId=21015, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e27419999e87, moduleTitle=8月28日全球新冠肺炎（COVID-19）疫情简报，确诊超2460万，美国制裁俄新冠病毒疫苗研发机构, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e27419999e87)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300415, encodeId=e157130041544, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=8月23日全球新冠肺炎（COVID-19）疫情简报，确诊超2335万，死亡超80万，中国疫苗研发进展迅速, objectType=article, longId=199861, objectId=d484199861f6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d484199861f6, replyNumber=0, likeNumber=53, createdTime=2020-08-24, rootId=0, userName=heli0118, userId=21015, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d484199861f6, moduleTitle=8月23日全球新冠肺炎（COVID-19）疫情简报，确诊超2335万，死亡超80万，中国疫苗研发进展迅速, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d484199861f6)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

研发

2020-05-29

lqvr (审核中...)

前往app查看评论内容

#研发#

抗艾滋病新药研发公司前沿生物IPO今日上市

2020-10-31

lqvr (审核中...)

前往app查看评论内容

#研发#

Nature:同期两篇！从基础研究到药物研发，李明团队发明“癌症环境免疫疗法”

2020-10-24

lqvr (审核中...)

前往app查看评论内容

#研发#

IDWeek 2020：默克公司将展示其广泛的抗感染药物研发管线

2020-10-24

lqvr (审核中...)

前往app查看评论内容

#研发#

9月16日全球新冠肺炎（COVID-19）疫情简报，确诊超3914万，日增再创新高，国外疫苗和药物研发均不顺利

2020-10-17

lqvr (审核中...)

前往app查看评论内容

#研发#

Sensible Medical：基于“透视墙”技术研发“穿戴”设备，测量肺积液管理心衰患者

2020-10-13

lqvr (审核中...)

前往app查看评论内容

#研发#

10月10日全球新冠肺炎（COVID-19）疫情简报，确诊超3709万，美国疫情强烈反弹，全球聚焦疫苗研发进度

2020-10-12

lqvr (审核中...)

前往app查看评论内容

#研发#

恒瑞医药正在瑞士巴塞尔建立欧洲临床研发中心

2020-10-10

lqvr (审核中...)

前往app查看评论内容

#研发#

百时美施贵宝斥131亿美元收购心血管药物研发商

2020-10-09

lqvr (审核中...)

前往app查看评论内容

#研发#

华西医院唐承薇教授：研发成果，中国硬件设备化的消化内镜AI产品获证

2020-10-07

lqvr (审核中...)

前往app查看评论内容

#研发#

翰尔西医疗：打破进口垄断，历经8年潜心研发推出国内领先的注射笔获NMPA认证

2020-10-07

lqvr (审核中...)

前往app查看评论内容

#研发#

CSCO 2020丨CDE高级审评员夏琳：肿瘤免疫治疗药物的临床研发和审评考虑

2020-09-24

lqvr (审核中...)

前往app查看评论内容

#研发#

辉瑞未来5年研发管线大公开！

2020-09-23

lqvr (审核中...)

前往app查看评论内容

#研发#

吉利德Kite副总裁离职、拜耳CEO任期延长、BMS肿瘤研发首脑加入Blueprint……

2020-09-21

lqvr (审核中...)

前往app查看评论内容

#研发#

华山陈向军、俞海：西尼莫德带给中国多发性硬化患者前沿疗法，新药研发可从四个方向突破

2020-09-17

lqvr (审核中...)

前往app查看评论内容

#研发#

非常时期埋头研发——一家医疗器械生产企业的突围之路

2020-09-15

heli0118 (审核中...)

前往app查看评论内容

#研发#

肝病研发企业新通药物完成Pre-IPO融资，预计明年在科创板上市

2020-09-12

heli0118 (审核中...)

前往app查看评论内容

#研发#

太刚了！真有人会为了新冠疫苗研发放弃赚钱…

2020-09-10

heli0118 (审核中...)

前往app查看评论内容

#研发#

第六批过度重复药品目录发布，企业应科学评估二甲双胍等302个品种研发风险

2020-09-09

heli0118 (审核中...)

前往app查看评论内容

#研发#

8月28日全球新冠肺炎（COVID-19）疫情简报，确诊超2460万，美国制裁俄新冠病毒疫苗研发机构

2020-08-29

heli0118 (审核中...)

前往app查看评论内容

#研发#

8月23日全球新冠肺炎（COVID-19）疫情简报，确诊超2335万，死亡超80万，中国疫苗研发进展迅速

2020-08-24

科室
- - 订阅+
  - 更多科室
工具
服务